Acrivon Therapeutics Files 2025 Annual Report

Ticker: ACRV · Form: ARS · Filed: Apr 30, 2026 · CIK: 0001781174

Acrivon Therapeutics, Inc. ARS Filing Summary
FieldDetail
CompanyAcrivon Therapeutics, Inc. (ACRV)
Form TypeARS
Filed DateApr 30, 2026
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: annual-report, pharmaceuticals, filing-update

TL;DR

ARS filed its 2025 annual report on 4/30/26. Check it for financials.

AI Summary

Acrivon Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 30, 2026, for the period ending December 31, 2025. The company, located at 480 Arsenal Way, Suite 100, Watertown MA 02472, operates in the Pharmaceutical Preparations sector. This filing provides a comprehensive overview of the company's performance and financial standing for the fiscal year 2025.

Why It Matters

This filing provides shareholders and potential investors with a detailed look at Acrivon Therapeutics' financial health and operational performance for the past fiscal year, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Acrivon Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

  • 2025-12-31 — Period of Report (The fiscal year end covered by the ARS filing.)
  • 2026-04-30 — Filing Date (The date Acrivon Therapeutics, Inc. submitted its ARS filing.)

Key Players & Entities

  • Acrivon Therapeutics, Inc. (company) — Filer of the ARS report
  • 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 (company) — Mailing and Business Address
  • 0001781174 (company) — CIK number for Acrivon Therapeutics, Inc.

FAQ

What is the primary business of Acrivon Therapeutics, Inc.?

Acrivon Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.

When was the Annual Report to Security Holders (ARS) filed?

The ARS filing was accepted on April 30, 2026.

What period does this ARS filing cover?

The period of report for this ARS filing is December 31, 2025.

What is the CIK number for Acrivon Therapeutics, Inc.?

The CIK number for Acrivon Therapeutics, Inc. is 0001781174.

Where is Acrivon Therapeutics, Inc. located?

Acrivon Therapeutics, Inc. is located at 480 Arsenal Way, Suite 100, Watertown MA 02472.

Filing Details

This Form ARS (Form ARS) was filed with the SEC on April 30, 2026 regarding Acrivon Therapeutics, Inc. (ACRV).

View full filing on EDGAR

View Full Filing

View this ARS filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.